Even though already known biomarkers such as 14-3-3 and tau or the detection of PrPSc by RT-QuIC has exhibited a high diagnostic accuracy to discriminate CJD from control cases [11, 15, 28], there is no marker available which shows a sensitivity close to 100%. This evidence concerns the gene MAPT and Creutzfeldt Jacob disease.